Clinical Trial Update: A Study to Assess the Safety, Tolerability, and Efficacy of IMVT-1402 in Participants With Cutaneous Lupus Erythematosus (CLE) [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating safety, tolerability, and efficacy of IMVT-1402 in adults with subacute and chronic cutaneous lupus erythematosus, currently…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cutaneous Lupus Erythematosus
• Subacute Cutaneous Lupus Erythematosus

Drugs mentioned

• IMVT-1402

Snippet

Sponsor: Immunovant Sciences GmbH | Conditions: Subacute Cutaneous Lupus Erythematosus, Chronic Cutaneous Lupus Erythematosus | Phase 2 | Status: RECRUITING